Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells

Published:2018-08 Issue:16 Volume:13 Page:2037-2050
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Oliveira Catarina¹²,Neves Nuno M¹²³,Reis Rui L¹²³,Martins Albino¹²,Silva Tiago H¹²

Affiliation:

1. 3B's Research Group – Biomaterials, Biodegradables & Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering & Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, 4805-017 Barco, Guimarães, Portugal

2. ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal

3. The Discoveries Centre for Regenerative & Precision Medicine, Headquarters at University of Minho, Avepark, 4805-017 Barco, Guimarães, Portugal

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2018-0004

Reference43 articles.

1. Cancer statistics, 2014

2. Breast cancer statistics, 2013

3. Breast Cancer

4. Rapid Review of Breast Cancer Treatment Side Effects and Dietary Supplement/Integrative Options from A to Z: What Helps, Harms, or Does Nothing?

5. Materials of marine origin: a review on polymers and ceramics of biomedical interest

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the promising role of chitosan delivery systems in breast cancer treatment: A comprehensive review;Carbohydrate Research;2024-11

2. Natural Polymers as a Carrier for the Effective Delivery of Antineoplastic Drugs;Current Drug Delivery;2024-02

3. Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives;Drug Discovery Today;2024-01

4. Opportunities and challenges of fucoidan for tumors therapy;Carbohydrate Polymers;2024-01

5. Naturally and Chemically Sulfated Polysaccharides in Drug Delivery Systems;Advanced Pharmacy;2023-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3